Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones

Clinical Science

Volumn 92, Issue 4, 1997, Pages 397-407

  Carstens, Jan ^a   Jensen, Kaare T ^a   Pedersen, Erling B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atrial natriuretic peptide; Lithium clearance; Sodium; Urodilatin

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; LITHIUM; TRACER; URODILATIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURETIC ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY DISTAL TUBULE; KIDNEY PLASMA FLOW; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE FUNCTION; MALE; NEPHRON; NORMAL HUMAN; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RENIN RELEASE; SECOND MESSENGER; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM URINE LEVEL; URINE FLOW RATE;

EID: 0030893097     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920397     Document Type: Article

References (48)

1. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG. Isolation and structural analysis of 'urodilatin', a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 1988; 66: 752-9.
2. Greenwald JE, Needleman P, Wilkins MR, Schreiner GF. Renal synthesis of atriopeptin-like protein in physiology and pathophysiology. Am J Physiol 1991; 260: F602-7.
3. Ritter D, Needlemann P, Greenwald JE. Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture. J Clin Invest 1991; 87: 207-17.
4. Greenwald JE, Ritter D, Tetens E, Rotwein PS. Renal expression of the gene for atrial natriuretic factor. Am J Physiol 1992; 263: F974-8.
5. + transport in rabbit inner medullary collecting duct (IMCD) cells (Abstract). J Am Soc Nephrol 1991; 2: 402.
6. Saxenhofer H, Fitzgibbon WR, Paul RV. Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cells. Am J Physiol 1993; 264: F267-73.
7. Drummer C, Fiedler F, K'nig A, Gerzer R. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man. J Am Soc Nephrol 1991; 1: 1109-13.
8. Heer M, Drummer C, Baisch F, Gerzer R. Long-term elevations of dietary sodium procedure parallel increase in the renal excretion of urodilatin and sodium. Pflhgers Arch 1993; 425: 390-394.
9. Goetz K, Drummer C, Zhu JL, Leadley R, Fiedler F, Gerzer R. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. J Am Soc Nephrol 1990; 1: 867-874.
10. Villarreal D, Freeman RH, Johnson RA. Renal effects of ANP (95-126), a new atrial peptide analogue, in dogs with experimental heart failure. Am J Hypertens 1991; 4: 508-15.
11. Abassi ZA, Powell JR, Golomb E, Keiser HR. Renal and systemic effects of urodilatin in rats with high-output heart failure. Am J Physiol 1992; 262: F615-21.
12. Bestle MH, Bie P. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol Scand 1993; 149: 77-83.
13. Gagelmann M, Hock D, Forssmann WG. Urodilatin (CDD/ANP 95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett 1988; 233: 249-54.
14. Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Shaw SG. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am. J. Physiol 1990; 259: F832-8.
15. Kentsch M, Ludwig D, Drummer C, Gerzer R, Mhller-Esch G. Haemodynamic and renal effects of urodilatin in healthy volunteers. Eur J Clin Invest 1992; 22: 319-325.
16. Elsner D, Muders F, Mhntze A, Kromer EP, Forssmann WG, Riegger GAJ. Efficacy of prolonged infusion of urodilatin (ANP-(95-126)) in patients with congestive heart failure. Am Heart J 1995; 129: 766-773.
17. Hummel M, Kuhn M, Bub A, Mann B, Schneider B, von Eickstedt K-W, Forssmann W-G, Hetzer R. Urodilatin, a new therapy to prevent kidney failure after heart transplantation. J Heart Transplant 1993; 12: 209-18
18. Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am J Physiol 1992; 262: R395-9.
19. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971; 28: 91-100.
20. Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984; 37: 217-223.
21. Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976; 67: 299-306.
22. Rask-Madsen J, Bruunsgaard A, Munck O, Nielsen MD, Worming H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1974; 9: 417-26.
23. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamid on renal plasma flow, glomerular Filtration rate and arginine-vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543-7.
24. Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol 1987; 17: 267-76.
25. Gaillard CA, Koomans HA, Rabelink AJ, Dorhout Mees EJ. Renal response to infusion versus repeated bolus injections of atrial natriuretic factor in man. Eur J Clin Pharmacol 1989; 36: 195-7.
26. Beutler JJ, Koomans HA, Bijlsma JA, Dorhout Mees EJ. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies. J Pharmacol Exp Ther 1990; 225: 1314-19
27. Eiskjaer H, Nielsen CB, Pedersen EB. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension. J Intern Med 1994; 236: 665-74.
28. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature (London) 1986; 324: 473-476.
29. Koomans HA, Boer WH, Mees EJD. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989; 36: 2-12.
30. Cuneo RC, Espiner A, Nicholls MG, Yandle TG, Joyce SL, Gilchrist NL. Renal, hemodynamic and hormonal responses to atrial natriuretic peptide infusions in normal man and effect of sodium intake. J Clin Endocrinol Metab 1986; 63: 946-953.
31. Valentin, J-P., Sechi, L.A., Qiu, C., Schambelan, M., Humphreys, M.H. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension 1993; 21: 432-8.
32. Mendez RE, Dunn BR, Troy JL, Brenner BM. Atrial natriuretic peptide and furosemide effects on hydraulic pressure in the renal papilla. Kidney Int 1988; 34: 36-42
33. Borenstein HB, Cupples WA, Sonnenberg H, Veres AT. The effect of a natriuretic atrial extract on renal haemodynamics and urinary excretion in anaesthetized rats. J Physiol 1983; 334: 133-40.
34. Kirchhoff K, Bub A, Marxen P, Forssmann WG. Urodilatin inhibits sodium reabsorption in the isolated perfused rat kidney. Exp Nephrol 1994; 2: 351-7.
35. Goetz KL. Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts. Am J Physiol 1991; 261: F921-32.
36. Light DB, Corbin J, Stanton BA. Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature (London) 1990; 344: 336-9.
37. Cottier C, Matter C, Weidmann P, Shaw S, Gnädinger MP. Renal response to low-dose infusion of atrial natriuretic peptide in normal man. Kidney Int 1988; 34 (Suppl.25): S72-8.
38. Solomon LR, Atherton JC, Bobinski H, Hillier V, Green R. Effect of low dose infusion of atrial natriuretic peptide on renal function in man. Clin Sci 1988; 75: 403-10.
39. Weidmann P, Gnädinger P, Ziswiler HR et al. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens 1986; 4 (Suppl. 2): S71-83.
40. Weidmann P, Hasler L, Gnädinger MP et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734-42.
41. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 1989; 256: R469-75.
42. Lang CC, Motwani JG, Coutie WJR, Struthers AD. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. Clin Sci 1992; 82: 619-23.
43. Riegger GAJ, Elsner D, Forssmann WG, Kromer EP. Effects of ANP-(95-126) in dogs before and after induction of heart failure. Am J Physiol 1990; 259: H1643-8.
44. Mhnzel T, Drexler H, Holtz J, Kurtz S, Just H. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure. Circulation 1991; 83: 191-201.
45. Saito Y, Nakao K, Nishimura K et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987; 76: 115-24.
46. Kentsch M, Ludwig D, Drummer C, Gerzer R, Mhller-Esch G. Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure. Eur J Clin Invest 1992; 22: 662-9.
47. Kentsch M, Drummer C, Gerzer R, Mhller-Esch G. Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failure. Eur J Clin Invest 1995; 25: 281-3.
48. Weder AB, Sekkarie A, Takiyyuddin M, Schork NJ, Julius S. Antihypertensive and hypotensive effects of atrial natriuretic factor in man. Hypertension 1987; 10: 582-9.